Envoy Medical (COCH) Return on Equity (2022 - 2025)
Historic Return on Equity for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to 1.19%.
- Envoy Medical's Return on Equity fell 2200.0% to 1.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.19%, marking a year-over-year decrease of 2200.0%. This contributed to the annual value of 1.95% for FY2024, which is 9800.0% up from last year.
- Envoy Medical's Return on Equity amounted to 1.19% in Q3 2025, which was down 2200.0% from 0.79% recorded in Q2 2025.
- In the past 5 years, Envoy Medical's Return on Equity ranged from a high of 3.51% in Q1 2024 and a low of 7.0% during Q4 2023
- Over the past 4 years, Envoy Medical's median Return on Equity value was 0.88% (recorded in 2025), while the average stood at 0.27%.
- As far as peak fluctuations go, Envoy Medical's Return on Equity tumbled by -62800bps in 2023, and later soared by 80700bps in 2024.
- Envoy Medical's Return on Equity (Quarter) stood at 0.72% in 2022, then crashed by -874bps to 7.0% in 2023, then skyrocketed by 115bps to 1.07% in 2024, then increased by 11bps to 1.19% in 2025.
- Its Return on Equity stands at 1.19% for Q3 2025, versus 0.79% for Q2 2025 and 0.96% for Q1 2025.